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ABSTRACT  
Aptamers are single-stranded nucleic acids that can selectively bind to essentially any molecule of 
choice. Because of their high stability, low cost, ease of modification and availability through selection, 
aptamers hold great promise in addressing key challenges in bioanalytical chemistry. In the past fifteen 
years many highly sensitive fluorescent aptamer sensors have been reported. However, few such sensors 
showed high performance in serum samples. Further challenges related to practical applications include 
detection in a very small sample volume and a low dependence of sensor performance on ionic strength. 
We report the immobilization of an aptamer sensor on a magnetic microparticle and the use of flow 
cytometry for detection. Flow cytometry allows the detection of individual particles in a capillary and 
can effectively reduce the light scattering effect of serum. Since DNA immobilization generated a highly 
negatively charged surface and caused an enrichment of counter ions, the sensor performance showed a 
lower salt dependence. The detection limits for adenosine are determined to be 178 and 167 M in 
buffer and in 30% serum, respectively. Finally, we demonstrated that the detection can be carried out in 
10 L of 90% human blood serum. 
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INTRODUCTION 
One of the key challenges in bioanalytical chemistry is the detection of disease-related proteins and 
metabolites in biological fluids.1 For practical applications, the sample volume should be as small as 
possible.2 For example, glucose sensors have revolutionized the health care of diabetic patients; 
currently only a few micro-liters of blood is needed.3 While protein enzymes and antibodies are the 
traditional molecules of choice for making biosensors, aptamers are emerging as a promising alternative 
due to their small sizes, high stability (especially DNA aptamers), ease of modification and 
immobilization, and excellent target recognition properties.4-16 Aptamers are single-stranded nucleic 
acids that can selectively bind to target molecules.17-19 Because of their useful properties, aptamers have 
been widely used for constructing biosensors. Among the various signal transduction methods, 
fluorescence has been the most often used due to its high sensitivity and versatility.5,20-27 In addition to 
intensity-based detection, fluorescence wavelength shift, anisotropy, lifetime, and energy transfer have 
all been reported for designing aptamer-based sensors.5  
 
Most fluorescent aptamer sensors involve cuvette-based measurements, in which the sensor and target 
analyte are mixed in a cuvette and the change of fluorescence signal is monitored with a fluorometer. 
With significant progresses being made, one of the intrinsic limitations of such cuvette-based detection 
is its incompatibility with serum samples. This is in part due to the cloudy optical appearance of serum; 
most light is absorbed or scattered, resulting in a very high background that masks fluorescence signal. 
For this reason, a majority of fluorescent sensors are demonstrated only in clean buffers and very few are 
shown to work in serum, in particular, undiluted serum.21,28 On the other hand, at least 100-500 L of 
sample is needed to fill a fluorescence cuvette. For practical application, it is desirable to decrease the 
sample volume to a level comparable to that used for glucose detection (e.g.  10 L).  
 
Even though serum samples are chemically complex, it has been demonstrated that aptamers can still 
selectively recognize their targets in serum.29-32 If one can separate the fluorescence detection step from 
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serum samples, fluorescent aptamer sensors can still be used for serum analysis.33,34 Among the various 
methods for DNA separation or buffer exchange, such as electrophoresis, dialysis, immobilization, 
centrifugation, and chromatography, we aim to achieve separation without actually performing an 
additional separation step (i.e. couple separation with detection). Herein, we report the immobilization 
of a fluorescent aptamer sensor on magnetic microparticles (MMPs) and the use of flow cytometry for 
detection of adenosine and related metabolites in serum. In flow cytometry, particles are analyzed 
individually through a capillary, and the optical path length in serum is significantly reduced. We 
demonstrate that as little as 10 L serum is sufficient for each assay, and the sensor shows a similar 
performance in serum as in buffer. In recent years, flow cytometry has become a routine technique in 
many hospitals for the analysis of blood samples and therefore flow-based analytical methods should be 
feasible in clinical or hospital settings. While flow cytometry has been used for aptamer-based cell 
detection,35-38 this is the first report to use this technique for small molecule analysis.  
 
EXPERIMENTAL SECTION 
Materials. The FAM-labeled biotinylated DNA aptamer and the complementary quencher-labeled 
DNA were purchased from Integrated DNA Technologies Inc (Coralville, IA). The DNA sequences are: 
5′-FAM–TCACTGACCTGGGGGAGTATTGCGGAGGAAGGTTTTTT-Biotin and 5′-
CCCAGGTCAGTG-Iowa Black FQ, and Iowa Black FQ is a fluorescence quencher. Streptavidin-
coupled 2.8 m Dynabeads M-270 were purchased from Invitrogen. Adenosine, other nucleosides, 
NaCl, Tris, and HEPES buffer were purchased from Mandel Scientific (Guelph, Ontario, Canada). ATP, 
AMP, and cAMP were purchased from Sigma. Human blood serum was purchased from Fisher 
Scientific. All buffers and solutions were made with Millipore water. Nucleoside solutions were 
prepared to be 50 mM. To fully dissolve adenosine, cAMP, and guanosine, the solutions were heated to 
a boiling temperature. 
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DNA Conjugation and Adenosine Detection. Before taking the MMPs out of the stock vial, the vial 
was vortexed to ensure that the particles were homogenously distributed. The particles were washed 
following the instructions provided by the vendor with 2 B&W buffer (10 mM Tris-HCl, pH 7.5, 1 
mM EDTA, 2 M NaCl) to remove the preservatives and were temporary stored in 1x B&W buffer 
before use. For DNA conjugation,  3 μL of 1 μM the fluorescent biotinylated DNA was incubated with 6 
μL of 1 μM quencher-labeled DNA in 100 μL 1 B&W buffer at 40 °C for 10 min and was slowly 
cooled down to room temperature. 1 μL of the MMPs were then coupled with the DNA at room 
temperature for 20-30 min. Excess DNA was discarded with the help of a magnet and the coated MMPs 
were washed with a small amount of 1x B&W buffer (30 μL  2) and buffer A (25mM HEPES/150mM 
NaCl) (30 μL  1). Various amount of adenosine was added to react with the aptamers functionalized 
MMPs in 50 μL of buffer A or in serum (diluted with the same buffer from 100% serum) for 20 min. 
The samples were then diluted to 300 μL with buffer A for flow cytometry analysis. To prepare 
centrifuged serum samples, a bench top centrifuge running at 15000 rpm for 20 min at 4 C was used. 
The fluorescence was measured either with a BD FACSVantage SE flow cytometer (with MMPs) or a 
Perkin Elmer LS-55 fluorometer (without MMPs). For flow cytometry assays, normal operation 
conditions with phosphate buffered saline based sheath fluids were used and at least 20000 events were 
counted for each sample. For assays with the fluorometer, 400 μL of the samples were used. The 
solutions were excited at 490 nm and fluorescence emission at 520 nm was collected.  
 
NaCl-Dependent Studies and Kinetics Assays. The sensor particles were prepared as described 
above and were diluted with buffers containing varying concentrations of NaCl. The fluorescence 20 
min after adding 2 mM adenosine was measured with the flow cytometer or fluorometer.  For kinetics 
studies, 10 μL of the sensor MMPs were used and the particles were finally dispersed in 100 μL buffer 
A. Adenosine was added to a final concentration of 2 mM or 10 mM. At designated time points, 10 μL 
of MMPs were taken out and diluted to 300 μL with buffer A for flow cytometry analysis. 
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-Potential Measurement. The -potential was measured with a Malvern Zetasizer nano ZS 
instrument with a dip-cell. 1 μL of the DNA conjugated MMPs were dispersed in 1 mL buffer A and the 
measurement was performed at 25 C with ten measurement circles.   
 
RESULTS AND DISCUSSION 
Sensor Design. To demonstrate the concept, we chose to use a well-characterized fluorescent aptamer 
sensor shown in Figure 1A.20,25,39 It contains an adenosine aptamer DNA labeled with a 5′-FAM and a 
3′-biotin. This aptamer can bind ATP, AMP, and adenosine,40 and has been widely used as a model 
system for designing aptamer-based sensors. The aptamer portion is colored in green and two short 
DNA spacers were added (in black and gray) between the aptamer and the two labels. After 
hybridization with a 12-mer DNA labeled with a 3′-quencher, the FAM emission is suppressed. 
Addition of adenosine (denoted as a red star in the figure) induces a structure switch in the aptamer to 
allow target binding, resulting in the release of the quencher-labeled DNA and an increased fluorescence 
signal.20,25 As shown in Figure 1C, this sensor can produce a 20-fold fluorescence enhancement in the 
presence of 10 mM adenosine in buffer A (25mM HEPES, pH 7.6, 150mM NaCl). However the 
fluorescence was largely obscured in a human blood serum sample (30% serum) with the same 
concentration of the sensor and adenosine (Figure 1D). The fluorescence enhancement was less than 1-
fold in this case due to the strong light scattering effect of serum, which represents a >20-fold decrease 
in the signal-to-background ratio. If 80% serum was used, fluorescence enhancement can barely be 
observed (see Supporting Information).   
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Figure 1. Non-immobilized (A) and immobilized (B) fluorescent aptamer sensor for adenosine based on 
the displacement of a quencher-labeled DNA by adenosine (adenosine is denoted as a red star). F = 
FAM fluorophore and Q = quencher. Fluorescence spectra of the non-immobilized sensor in buffer (C) 
and in 30% serum (D). Flow cytometry histograms of the immobilized sensor in buffer (E) and in 30% 
serum (F).  
To minimize serum-induced optical background, this sensor was immobilized on a streptavidin-coated 
MMP (diameter = 2.8 m) through the biotin label as shown in Figure 1B. Five thymine nucleotides 
were introduced as a spacer between the biotin and the aptamer to minimize possible effects of surface 
immobilization on aptamer binding. Due to the very high binding affinity between biotin and 
streptavidin, a simple mixing and incubation is sufficient for immobilization. As specified by the 
vendor, on average 1.8106 single-stranded DNAs can be immobilized on the surface of each particle, 
although no information on the DNA length was given. We estimated that 1.2106 DNAs were attached 
to each particle (DNA length = 38 mer, see Supporting Information), which is comparable with the 
vendor’s value. Free DNAs in the supernatant were removed with the help of a magnet. Release of the 
quencher-labeled strand by the target molecule renders the MMP highly fluorescent and can be detected 
by flow cytometry. 
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Under an optical microscope, the aptamer-functionalized MMPs were fully dispersed and no 
aggregates were observed, which makes flow cytometry analysis uncomplicated. A representative flow 
cytometry histogram of the immobilized adenosine sensor in buffer A is shown in Figure 1E. The x-axis 
is the FAM fluorescence intensity and the y-axis is the number of particles. Under experimental 
conditions, unmodified MMPs have an average fluorescence of ~2 (Figure 1E, the black curve). After 
adding the FAM-labeled biotinylated DNA, the peak shifted to ~110 (red curve). With the quencher-
labeled DNA, the fluorescence shifted back to ~8 (blue curve), which corresponds to a 14-fold 
fluorescence decrease. This indicates that a high DNA hybridization efficiency was maintained on the 
particle surface. After incubating with 10 mM adenosine at room temperature for 20 min, the 
fluorescence signal was almost fully recovered (green curve), suggesting that adenosine can induce the 
structure switch of the immobilized aptamer and release the quencher-labeled DNA. A similar degree of 
fluorescence enhancement was also observed in serum samples as shown in Figure 1F (comparing the 
blue and green curves), suggesting that the effect of serum on fluorescence detection was reduced 
through the use of flow cytometry. The nozzle diameter of the flow cytometer is 70 m, which 
represents a >50-fold reduction of light path length in serum compared to a 4 mm micro-cuvette. 
Dilution of serum by the sheath fluid should have minimal effects on the observed background 
reduction, because both the light path length in serum and the serum concentration contribute to light 
scattering, and the product of these two parameters should be a constant according to Beer’s law 
(assuming serum only diffuses laterally). We also noticed that the histogram was broadened in the 
presence of serum, although the peak intensity stayed roughly the same (e.g. the red peaks with 
fluorescence of ~100 in Figure 1E and F). This broadening was attributed to the increased viscosity of 
the flow sample,41 which decreased particle flow rate in serum to produce a broader peak in the 
histogram.42   
 
The major difference between Figure 1F and 1E is that the population of “particles” with very low 
fluorescence (e.g. fluorescence value <10) was significantly increased in the serum samples, possibly 
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due to serum protein aggregates and cell debris that may have a similar size as the MMPs but are non-
fluorescent. To quantitatively understand the effect of serum, the light scattering of the particles and its 
correlation with fluorescence intensity were studied. In buffer, FAM-labeled MMPs in the forward/side 
scatter histogram are concentrated in a small region (Figure 2A), suggesting that these MMPs are mono-
dispersed. The position of this population was used to define a gate (the red circle) for subsequent 
analysis. Because of the FAM label, a population with fluorescence intensity of ~100 was observed in 
the fluorescence/side scatter plot (Figure 2B), and in the fluorescence histogram (Figure 2C). Figure 2D-
F show the same plots for serum (100% serum, no MMPs), and a significant number of serum particles 
were in the gate, which were also counted as “particles”. These particles, however, were non-fluorescent 
(Figure 2E, F). When the fluorescent MMPs were mixed with serum, the resulting histograms were 
essentially a simple addition of the two individual components (Figure 2G-I). Even though there are 
significantly more serum particles than MMPs under experimental conditions (within the gate 
serum:MMP = 29:1), these two populations can be clearly separated based on fluorescence.    
 
Figure 2. Histograms of forward (FSC)/side (SSC) scatter (A, D, G), fluorescence/side scatter (B, E, H), 
and fluorescence (C, F, I) of fluorescent MMPs in buffer (A-C), pure serum (D-F), and fluorescent 
MMPs in serum (G-I). 
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NaCl-Dependent Studies. To optimize the detection conditions, systematic studies on the NaCl-
dependent behavior of both the non-immobilized and immobilized sensor were performed in buffer. The 
buffer contained 25 mM HEPES, pH 7.6 with varying concentrations of NaCl up to 1 M (Figure 3). For 
the non-immobilized sensor, the assays were performed in a cuvette with a fluorometer. There is a clear 
trend of signal inhibition at high salt concentrations (Figure 3A, open squares). In the presence of 1 M 
NaCl, the signal decreased by ~70% compared to that in 25 mM NaCl. The adenosine sensing process 
can be considered to be a competition between the aptamer binding to adenosine and to the quencher-
labeled DNA (Figure 1A). It is known that double-stranded DNAs are more stable in the presence of 
higher salt while the aptamer complex stability may be less affected by salt because not every nucleotide 
in the aptamer is paired.43,44 This can explain the suppressed signal enhancement for the non-
immobilized sensor. Interestingly, we observed a much less pronounced salt-dependent response for the 
immobilized sensor analyzed by flow cytometry (Figure 3B). In the range of 25 to 300 mM NaCl, the 
average fluorescence stayed at ~50 after reacting with 2 mM adenosine. The background signal in the 
absence of adenosine was also more stable across the 1 M salt range tested (solid circles). The ability to 
generate less salt-dependent signals is very important, because the ionic strengths are sometimes 
































































Figure 3. The fluorescence signal of the non-immobilized (A) and immobilized sensor (B) with 
increasing NaCl concentrations. In both plots, the sensor signals before and 20 min after adding 2 mM 
adenosine were compared.  
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DNA is a polyanion and each phosphate carries a negative charge under physiological pH. DNA 
immobilization creates a densely packed and highly negatively charged layer on the microparticle 
surface. Based on the particle size and DNA density, it is estimated that there is one DNA every 20 nm2, 
and each DNA carries 50 negative charges at pH 7.6. A direct consequence of a highly negatively 
charged surface is the enrichment of counterions (in this case, Na+), and the enrichment factor compared 
to the bulk concentration is given by the Boltzmann equation )/|exp(| Tke B , where  is the surface 
potential, e is the elemental charge, kB is the Boltzmann constant, and T is temperature in Kelvin. The 
measured  potential with 25 mM NaCl at pH 7.6 was -22 mV. This, however, was the potential at the 
plane of shear and the true surface potential should be higher. If  potential is used as the surface 
potential for a conserved estimate, an enrichment factor of 2.2 is obtained for 25 mM NaCl to give a 
local [Na+] of 55 mM. Because the enrichment factor increases exponentially with the surface potential, 
the actual enrichment should be much higher. On the other hand, the surface potential decreases with 
increasing salt concentration (see Supporting Information). Therefore, the counterion enrichment factor 
should decrease in high salt. The overall effect is a higher enrichment factor in low salt and a lower 
enrichment in high salt. This may explain the salt independent behavior for the immobilized sensor. The 
drastically increased local counterion concentration around DNA-functionalized gold nanoparticles has 
also been suggested to be responsible for protecting DNA from nuclease degradation by Mirkin and co-
workers.45    
 
Reaction Kinetics. To understand the time-dependent signal change of the immobilized sensor, 
kinetic studies have been performed by taking aliquots out and analyzing by flow cytometry at 
designated time points after adding 2 or 10 mM adenosine. As can be observed in Figure 4, most of 
fluorescence change occurred in the first 5 min and the signals reached saturation in about 20 min for 
both samples. Therefore, we chose to use a 20 min reaction time for the immobilized sensor for most 
studies in this work. A higher adenosine concentration produced a higher final signal, which formed the 
basis for quantitative analysis. The fact that each sample can quickly reach a stable final signal suggests 
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that the immobilized system can reach equilibrium, just like the non-immobilized sensor,20 and the 
released quencher-labeled DNA can still re-hybridize with the immobilized aptamer DNA. Otherwise, 
the fluorescence signal in the 2 mM adenosine sample should continue to increase until it reached the 
same final value as in the 10 mM one.   
Time (min)































Figure 4. Kinetics of fluorescence enhancement for the immobilized sensor in the presence of 2 and 10 
mM adenosine analyzed with flow cytometry.  
Sensitivity and Selectivity. With the optimized detection conditions, the sensitivity and selectivity of 
the sensor was examined in buffer A with a 20 min reaction time. Figure 5A shows the flow cytometry 
histograms of the sensor in the presence of varying concentrations of adenosine, and a gradual shift in 
the peak fluorescence can be observed. If the average fluorescence in Figure 5A is plotted against 
adenosine concentration (Figure 5B), an overall sigmoid shaped curve is obtained with a slow signal 
increase at low target concentrations followed by a sharp rise at high concentrations. The low 
concentration region can be fit to a linear response (inset) with a detection limit of 178 M adenosine 
based on the 3/slope calculation. The selectivity of the sensor was also tested with 10 mM of various 
nucleosides. As can be seen from Figure 5C, with 10 mM uridine, cytodine, or guanosine, the average 
fluorescence stayed at the same position as the untreated sensor, suggesting that the high selectivity of 
the original aptamer was maintained. The response of the sensor to several analogs of adenosine, 
including ATP, AMP, and cAMP was also tested (Figure 5D), and the sensor is also sensitive to these 
compounds but with slightly lower responses, which is consistent with literature reports.20,40 The 
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sensitivity of the sensor is high enough for detecting some of these molecules under physiological 
conditions (e.g. >2 mM for ATP).46 To distinguish these analogs individually, however, aptamers with 
better selectivity are needed.47   
 
Figure 5. Flow cytometry histograms of the sensor in the presence of varying concentration of 
adenosine (A). Sensitivity (B) and selectivity (C, D) of the immobilized adenosine sensor in buffer. In 
(C and D), 10 mM adenosine, adenosine analogs or other nucleosides were used. 
 
Detection in Serum. One of the main motivations of this study is to test whether the immobilized 
aptamer sensor can be used for detection in blood serum. We have shown in Figure 1F that this sensor 
indeed works in serum. For quantitative detection, samples with 30% serum were spiked with varying 
concentrations of adenosine and other procedures were the same as in the case of detection in clean 
buffers. The fluorescence signal increased with increasing adenosine and a detection limit of 167 M 
was obtained (Figure 6A), which is similar to the detection limit in buffer A. The immobilized sensor 
also showed a very high selectivity in serum (Figure 6B), and only adenosine induced a fluorescence 




We next challenged the sensor with 90% serum. Pure serum was not tested because 10% of the 
volume was used to add adenosine. As can be observed in Figure 6C, even though very high serum 
peaks were present in these samples, 200 M adenosine can still be detected (inset). If the serum 
samples were centrifuged (with adenosine already dissolved) to remove aggregated proteins and cell 
debris before reacting with the sensor, the number of residual serum particles was comparable to that of 
MMPs (Figure 6D), and centrifugation did not change the sensitivity of the sensor.  
 
 
Figure 6. Sensitivity (A) and selectivity (B) of the immobilized adenosine sensor in 30% serum. Flow 
cytometry histograms of the sensor response to varying concentrations of adenosine in 90% serum (C) 
and in 90% serum after centrifugation (D) to remove aggregated proteins in serum. (C) and (D) share the 
figure legend, and the inset of (C) highlights the MMP population.  
In all the experiments reported so far, the sensor particles were dispersed in >50 L of samples. 
Because the sensor was immobilized, it is possible to perform detection in a very small volume. To 
demonstrate this, the sensor was reacted in 10 L of 90% serum with varying concentrations of 
adenosine. Because a volume of 10 L was insufficient for flow cytometry-based detection, a dilution 
with buffer A to 300 L was performed right before the flow cytometry analysis. Although the 
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adenosine concentration was diluted by 30-fold, a detection limit of ~ 200 M was achieved for both the 
non-centrifuged (Figure 7A) and centrifuged (Figure 7B) serum. Therefore, this method can be applied 
for the analysis of very tiny volume of samples. With such a low volume of serum and centrifugation to 
remove large particles in serum, the population from serum is only 5% of the MMPs. The fact that the 
sensor was immobilized represents another advantage of this approach. Although the volume was 
increased, the fluorescence signal was not diluted because of immobilization.  
 
Figure 7. Detection of adenosine in 10 L of serum samples for the non-centrifuged (A) and centrifuged 
(B) serum.  
 
Advantage of Sensor Immobilization. There are several important features for this new detection 
method. First, based on the knowledge that aptamers can still selectively bind their targets in serum, 
flow cytometry provides a convenient means for separating fluorescence detection from the serum 
sample matrix. By applying a gate on the sensor particles, a large fraction of particles are outside the 
gate and are not considered for analysis. For the serum originated events within the gate, they are almost 
non-fluorescent and can be distinguished from the sensor particles in the presence of adenosine. 
Therefore, fluorescent aptamer sensors can be used for serum analysis through a simple immobilization 
step. Second, the amount of DNA used for detection can be significantly reduced. For a typical 
experiment in a cuvette (e.g. 400 L of 50 nM DNA), 20 pmol DNA is needed for each assay. For the 
immobilized sensor, if 10,000 particles are counted and each particle contains 1.2106 DNAs, only 17 
fmol DNA is needed. This represents a >1000-fold reduction in DNA usage. Even if the number of 
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particles is increased by 10-fold to allow a faster detection, the save in DNA is still greater than 100-
fold. Third, the immobilized sensor shows a lower dependence on the sample ionic strength. Fourth, 
immobilization allows the use of as low as 10 L of sample. Finally, flow cytometry is known for its 
multiplex capability. By using different aptamers, fluorophores and particle sizes, multiple targets can 
potentially be detected in one-pot with a very small volume of blood sample. 
 
CONCLUSIONS  
In conclusion, we have developed a new aptamer-based assay with flow cytometry. This method takes 
advantage of the unique capability of flow cytometry in detecting particles individually in a capillary and 
thus drastically decreasing the light path length in serum. The sensor particles showed a comparable 
performance in blood serum as in clean buffers. We also observed a lower salt dependence of the 
immobilized sensor, which was attributed to the enrichment of couterions on the particle surface by the 
densely immobilized DNA. The method allows sensitive and selective detection in a small volume of 
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SUPPORTING INFORMATION AVAILABLE 
Quantification of DNA on particle surface, flow cytometry histograms of the sensor in buffer and in 
serum, and discussion about surface potential and enrichment of counterions. This material is available 
free of charge via the Internet at http://pubs.acs.org. 
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